UCB Announces Partnership With Microsoft To Expedite Treatment Options

Biopharmaceutical company UCB has entered a multi-year collaboration with technology company Microsoft to discover data-driven insights and produce effective treatments in immunology and neurology. UCB looks to utilize Microsoft’s computing power and Artificial Intelligence (AI) capabilities. ..